Log In

Peter Barton Hutt


Peter HUTT, American lawyer. Award, M. Institute of Medicine, N.A.S. since 1970, Advisory Board, Tufts Center for Study of Drug Development since 1976, University Virginia, Center for Advanced Studies 1982, National Committee on New Drugs for Cancer and AIDS since 1988; Board of directors of numerous cos.


HUTT, Peter was born on November 16, 1934 in Buffalo, New York, United States. Son of Lester Ralph Hutt and Louise Rich Fraser.


Bachelor magma cum laude, Yale University, 1956. Bachelor of Laws, Harvard University, 1959. Master of Laws, New York University, 1960.


Associate Covington & Burling, Washington, 1960-1968, partner, 1968—1971, 1975—2004, senior counsel, since 2004. Chief counsel Food and Drug Administration, 1971-1975. Board director Livining Proof, Cambridge, Massachusetts, since 2007, CV Therapeutics Inc., Palo Alto, California, 2000—2008, Favrille, Inc., San Diego, 2003—2008, Momenta, Inc., Cambridge, Massachusetts, since 2001, Q Therapeutics, Salt Lake City, since 2002, Ista Pharmaceuticals, Inc., Irvine, California, since 2002, Pervasis Therapeutics, Inc., Boston, since 2004, Introgen Therapeutics, Inc., Houston, 2004—2008, Xoma, Inc., Berkeley, California, since 2005, California HealthCare Institute, San Diego, since 1996, Life Line Screening, Cleveland, since 2006, Concert Pharmaceuticals, Inc., Lexington, Massachusetts, since 2006, Endotis Pharma, Romainville, France, since 2008, Bind Bioscis.

Inc., Cambridge, since 2008, Seventh Sense Inc., Cambridge, Massachusetts, since 2008, Celera Corporation, Alameda, California, since 2008, Nana Medical Systems, Austin, Texas, since 2008, DBV Technologies, Paris, since 2009, Keck Graduate Institute Applied Life Science, Claremont, California, since 2007, Aeras Global Tuberculosis Vaccine Foundation, Rockville, Maryland, since 2006, DBV Technologies, Paris, since 2009, Selecta Bioscis., Inc., Watertown, Massachusetts, since 2010. Advisory committee to director National Institutes of Health, 1976—1981. Committee on research training National Academy of Sciences, 1976—1980.

Counsel to Alcoholic Beverage Medical Research Foundation, 1984—1985, chairman board director, 1986—1992. Member National Committee to Review Current Proceedings for Approval of New Drugs for Cancer and Acquired Immune Deficiency Syndrome, National Cancer Institute, 1988—1990. Member national board Scripps Clinic and Research Foundation, La Jolla, 1977—1985, 1990—1995.

Member international board Scripps Institutions of Medicine and Science, 1995—2002, Center for Study Drug Development, Tufts University Center, 1976—1999, Center for Advanced Studies, U.Va., 1982—2002, Institute for Health Policy Analysis, since 1982, American Council of Scientific and Health, since 2006, American Pharmaceutical Institute, Washington, 1988—1992. Committee on food laws and regulations Institute Food Technology. Advisory committee Progress and Freedom Foundation, 1994—1997.

Advisory board Frazier Healthcare Investments, Seattle, 1993—1999, Sprout Group, New York and Menlo Park, since 1993, Polaris Venture Partners, Waltham, since 1995, Kearny Venture Partners, San Francisco, since 2006, Vanguard Medica Ltd., Guildford, England, 1993—1999, Columbia University School Public Health, 1997—2004, Sherbrook Capital Health & Wellness Fund, Lexington, Massachusetts, since 1999, Burrill Neutraceuticals, San Francisco, since 2000, New Leaf Venture Partners, New York, Menlo Park, California, since 2005, Sirtris Phrams., Inc., Cambridge, Massachusetts, since 2006, Magen BioScis., Inc., Cambridge, 2006—2009, Aretais, Inc., since 2008, Gelesis Inc., since 2008, Yale School Public Health, New Haven, since 2011. Panel member United States Congressional Office Technology Assessment. Lecturer on food and drug law Harvard University, since 1994, Stanford University, 1998.

Panel on administrative restructuring National Institutes of Health, National Academy Public Administration, 2004—2006. Member working group Acquired Immune Deficiency Syndrome division National Institute Allergy and Infectious Diseases, 2005—2006. Member science board subcommittee on state of Food and Drug Administration science Food and Drug Administration, 2006—2007.


  • Bar: New York 1959, District of Columbia 1961, Supreme Court of the United States Court 1967.



Board directors Sidwell Friends School, Washington, 1976-1984. Board directors Legal Action Center, New York City, 1976-2003, vice-chairman, 1984-1998. Board directors Foundation for biomedical Research, since 1976, vice chairman, since 1989.

Trustee Washington Lawyers Committee for Civil Rights and Urban Affairs, since 1976, Food and Drug Law Institute, 2001-2005. Board directors Society Risk Analysis, 1985-1988, 89-92, counsel, since 1992. Member visiting committee Harvard School Public Health, 1980-1986.

Fellow: Society Risk Analysis. Member: Institute Medicine of National Academy of Sciences (Development of Drugs and Vaccines Against Acquired Immune Deficiency Syndrome roundtable 1988-1994, board on health care services 1998—2002).


  • Other Interests

    Research on the history of govt, regulation of food and drugs.


Children: Katherine Zurn, Peter Barton, Sarah Henderson, Everett Fraser.

Lester Ralph Hutt

Louise Rich (Fraser) Hutt

Katherine Zurn Hutt

Peter Barton Hutt

Sarah Henderson Hutt

Everett Fraser Hutt